ADB-CHMINACA

Error creating thumbnail:

ADB-CHMINACA-fixed.svg

ADB-CHMINACA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body.

Chemical Structure and Properties

ADB-CHMINACA belongs to the indazole-3-carboxamide family of synthetic cannabinoids. Its chemical structure includes an indazole core, which is a bicyclic structure composed of a benzene ring fused to a pyrazole ring. The full chemical name of ADB-CHMINACA is N-[[(1-amino-3,3-dimethyl-1-oxobutan-2-yl)]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide]].

Pharmacology

As a synthetic cannabinoid, ADB-CHMINACA acts as a potent agonist at the CB1 receptor and CB2 receptor in the endocannabinoid system. These receptors are primarily found in the central nervous system and immune system, respectively. Activation of these receptors by ADB-CHMINACA can lead to a range of effects, including euphoria, anxiolysis, and analgesia, as well as potential adverse effects such as tachycardia, hypertension, and psychosis.

Legal Status

The legal status of ADB-CHMINACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, ADB-CHMINACA is listed as a Schedule I controlled substance under the Controlled Substances Act.

Health Risks and Toxicity

The use of ADB-CHMINACA has been associated with numerous adverse health effects. These can include acute intoxication, seizures, cardiovascular complications, and renal failure. Due to its high potency and the variability in the composition of synthetic cannabis products, users are at significant risk of overdose and severe toxicity.

Detection in Biological Samples

ADB-CHMINACA and its metabolites can be detected in biological samples such as urine and blood using techniques like liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS). These methods are commonly used in forensic toxicology to confirm exposure to synthetic cannabinoids.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Controlled Substances Act